📰 Diagnostics Development News
Page 2 - Diagnostics Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diagnostics Development. Real-time updates on events, politics, business and more.
January 26, 2023
Cancer Biomarkers Market study by "Data Bridge Market Research" provides details about the market dynamics affecting this market, Market scope, Market
January 18, 2023
Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones - read this article along with other careers information, tips and advice on BioSpace
January 17, 2023
Aeterna Zentaris focused on accelerating recruitment for ongoing DETECT trial and efforts to partner rights to Macrilen™ in the U.S. and CanadaCompany...
January 17, 2023
17.01.2023 - Aeterna Zentaris focused on accelerating recruitment for ongoing DETECT trial and efforts to partner rights to Macrilen in the U.S. and CanadaCompany continues to build growing body of data across its development pipeline, advancing towards go/no-go ... Seite 1
October 6, 2022
/PRNewswire/ -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025" report...
October 6, 2022
/PRNewswire/ -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025" report...
August 22, 2022
/PRNewswire/ -- The "Extracellular Vesicles 2022: Biology, Disease & Medicine" conference has been added to ResearchAndMarkets.coms offering. The host is...
August 11, 2022
NEW YORK, Aug. 11, 2022 /PRNewswire/ -- According to a Comprehensive Research Report by Data Bridge Market Research on Global Cancer Diagnostics Market research report is an expert's analysis
August 11, 2022
/PRNewswire/ -- According to a Comprehensive Research Report by Data Bridge Market Research on Global Cancer Diagnostics Market research report is an experts...
April 25, 2022
FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today